Skip to main content

Table 2 System suitability

From: Cefoperazone rapidly and sensitive quantitative assessment via a validated RP-HPLC method for different dosage forms, in-use stability, and antimicrobial activities

Replicate

Flow (1.0 mL)

Buffer 80%

First analyst

Day—1

Column—1

Flow (0.9 mL)

Flow (1.1 mL)

Buffer (82.5%)

Buffer (77.5%)

Second analyst

Day—2

Column—2

Column—3

Weight(g)/100 mL

0.01094

0.01094

0.01094

0.01092

0.01094

0.01091

0.01095

0.01097

0.01091

1

3744.7

4138.2

3443

3779.1

3517.1

3734.7

3794.2

3864.8

3765.9

2

3746.1

4115.3

3441.3

3756.2

3486

3735.2

3782.9

3896.9

3781.2

3

3730.9

4164.9

3434.5

3784.0

3513.5

3741.6

3846.9

3908.0

3806.3

4

3785.2

4155.2

3444.2

3784.5

3515.4

3722.9

3794.1

3905.9

3799.9

5

3791.3

4128.8

3435.8

3754.8

3554.2

3723.5

3759.1

3887.8

3796.6

6

3753.8

4133.0

3429.5

3754.7

3524.5

3747.1

3737.3

3904.3

3859.8

Mean P.A

3758.7

4139.2

3438.1

3768.9

3518.5

3734.2

3785.8

3894.6

3801.6

STDV

24.2

18.1

5.7

15.1

21.9

9.6

37.3

16.4

32.0

RSD

0.64

0.44

0.17

0.40

0.62

0.26

0.98

0.42

0.84

Tailing

1.15979

1.20087

1.15984

1.14816

1.08537

1.11781

1.11781

1.08023

0.93333

Plates

5411

5700

4864

6078

4915

5179

5179

5135

5017